245 related articles for article (PubMed ID: 24996784)
1. Langerhans cell histiocytosis: 23 years' paediatric experience highlights severe long-term sequelae.
Martin A; Macmillan S; Murphy D; Carachi R
Scott Med J; 2014 Aug; 59(3):149-57. PubMed ID: 24996784
[TBL] [Abstract][Full Text] [Related]
2. Craniospinal Langerhans cell histiocytosis in children: 30 years' experience at a single institution.
Davidson L; McComb JG; Bowen I; Krieger MD
J Neurosurg Pediatr; 2008 Mar; 1(3):187-95. PubMed ID: 18352762
[TBL] [Abstract][Full Text] [Related]
3. Late outcomes in children with Langerhans cell histiocytosis.
Chow TW; Leung WK; Cheng FWT; Kumta SM; Chu WCW; Lee V; Shing MMK; Li CK
Arch Dis Child; 2017 Sep; 102(9):830-835. PubMed ID: 28442470
[TBL] [Abstract][Full Text] [Related]
4. Treatment of multisystem Langerhans cell histiocytosis. Results of the DAL-HX 83 and DAL-HX 90 studies. DAL-HX Study Group.
Minkov M; Grois N; Heitger A; Pötschger U; Westermeier T; Gadner H
Klin Padiatr; 2000; 212(4):139-44. PubMed ID: 10994540
[TBL] [Abstract][Full Text] [Related]
5. Langerhans cell histiocytosis in children less than 2 years of age.
Kusuma Kumary P; Priyakumari T; Chellam VG; James FV; Nair MK
Indian Pediatr; 1999 Jan; 36(1):29-36. PubMed ID: 10709120
[TBL] [Abstract][Full Text] [Related]
6. Intensification of induction therapy and prolongation of maintenance therapy did not improve the outcome of pediatric Langerhans cell histiocytosis with single-system multifocal bone lesions: results of the Japan Langerhans Cell Histiocytosis Study Group-02 Protocol Study.
Morimoto A; Shioda Y; Imamura T; Kudo K; Kitoh T; Kawaguchi H; Goto H; Kosaka Y; Tsunematsu Y; Imashuku S;
Int J Hematol; 2018 Aug; 108(2):192-198. PubMed ID: 29594922
[TBL] [Abstract][Full Text] [Related]
7. Disease course and late sequelae of Langerhans' cell histiocytosis: 25-year experience at the University of California, San Francisco.
Willis B; Ablin A; Weinberg V; Zoger S; Wara WM; Matthay KK
J Clin Oncol; 1996 Jul; 14(7):2073-82. PubMed ID: 8683239
[TBL] [Abstract][Full Text] [Related]
8. The frequency and natural history of diabetes insipidus in children with Langerhans-cell histiocytosis.
Dunger DB; Broadbent V; Yeoman E; Seckl JR; Lightman SL; Grant DB; Pritchard J
N Engl J Med; 1989 Oct; 321(17):1157-62. PubMed ID: 2797079
[TBL] [Abstract][Full Text] [Related]
9. Permanent disabilities in childhood survivors of Langerhans cell histiocytosis.
Kusumakumary P; James FV
Pediatr Hematol Oncol; 2000; 17(5):375-81. PubMed ID: 10914047
[TBL] [Abstract][Full Text] [Related]
10. Langerhans cell histiocytosis: retrospective evaluation of 123 patients at a single institution.
Braier J; Chantada G; Rosso D; Bernaldez P; Amaral D; Latella A; Balancini B; Masautis A; Goldberg J
Pediatr Hematol Oncol; 1999; 16(5):377-85. PubMed ID: 10505313
[TBL] [Abstract][Full Text] [Related]
11. Diabetes insipidus associated with Langerhans cell histiocytosis: is it reversible?
Broadbent V; Pritchard J
Med Pediatr Oncol; 1997 Apr; 28(4):289-93. PubMed ID: 9078326
[TBL] [Abstract][Full Text] [Related]
12. Pulmonary Langerhans cell histiocytosis: a variable disease in childhood.
Odame I; Li P; Lau L; Doda W; Noseworthy M; Babyn P; Weitzman S
Pediatr Blood Cancer; 2006 Dec; 47(7):889-93. PubMed ID: 16276522
[TBL] [Abstract][Full Text] [Related]
13. [Treatment of langerhans cell histiocytosis in children].
Bilić E; Bojanić K; Pavlović M; Konja J; Femenić R; Dapić T; Antabak A; Anticević D; Murat-Susić S; Husar K; Potocki K; Rajić L
Lijec Vjesn; 2011; 133(11-12):376-84. PubMed ID: 22329293
[TBL] [Abstract][Full Text] [Related]
14. [Langerhans-cell histiocytosis (histiocytosis X); 20-year experience in the Emma Kinderziekenhuis, 1969-1988].
Egeler RM; de Kraker J; Voûte PA
Ned Tijdschr Geneeskd; 1993 May; 137(19):955-60. PubMed ID: 8497330
[TBL] [Abstract][Full Text] [Related]
15. Central diabetes insipidus in children and young adults.
Maghnie M; Cosi G; Genovese E; Manca-Bitti ML; Cohen A; Zecca S; Tinelli C; Gallucci M; Bernasconi S; Boscherini B; Severi F; Aricò M
N Engl J Med; 2000 Oct; 343(14):998-1007. PubMed ID: 11018166
[TBL] [Abstract][Full Text] [Related]
16. Improved outcome in the treatment of pediatric multifocal Langerhans cell histiocytosis: Results from the Japan Langerhans Cell Histiocytosis Study Group-96 protocol study.
Morimoto A; Ikushima S; Kinugawa N; Ishii E; Kohdera U; Sako M; Fujimoto J; Bessho F; Horibe K; Tsunematsu Y; Imashuku S;
Cancer; 2006 Aug; 107(3):613-9. PubMed ID: 16804933
[TBL] [Abstract][Full Text] [Related]
17. Growth and endocrine disorders in multisystem Langerhans' cell histiocytosis.
Nanduri VR; Bareille P; Pritchard J; Stanhope R
Clin Endocrinol (Oxf); 2000 Oct; 53(4):509-15. PubMed ID: 11012577
[TBL] [Abstract][Full Text] [Related]
18. Permanent consequences in Langerhans cell histiocytosis patients: a pilot study from the Histiocyte Society-Late Effects Study Group.
Haupt R; Nanduri V; Calevo MG; Bernstrand C; Braier JL; Broadbent V; Rey G; McClain KL; Janka-Schaub G; Egeler RM
Pediatr Blood Cancer; 2004 May; 42(5):438-44. PubMed ID: 15049016
[TBL] [Abstract][Full Text] [Related]
19. Langerhans' cell histiocytosis: experience from a single center.
Bansal D; Marwaha RK; Trehan A; Gupta V; Varma N
Indian Pediatr; 2008 Aug; 45(8):685-8. PubMed ID: 18723913
[TBL] [Abstract][Full Text] [Related]
20. Clinical outcomes of radiation therapy in the management of Langerhans cell histiocytosis.
Kotecha R; Venkatramani R; Jubran RF; Arkader A; Olch AJ; Wong K
Am J Clin Oncol; 2014 Dec; 37(6):592-6. PubMed ID: 23466581
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
